Current pharmacotherapy for endometriosis
The DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index.
Abstract
IMPORTANCE OF THE FIELD: Medical therapy is the most commonly used treatment for endometriosis. In particular, the administration of hormonal therapies aims to improve symptoms with minimal adverse effects. AREAS COVERED IN THIS REVIEW: Observational and randomized studies evaluating the efficacy of medical therapy on symptoms associated with endometriosis were reviewed. We searched Medline, Embase and the Cochrane Library up to December 2009. WHAT THE READER WILL GAIN: The reader will obtain information on the available medical therapies used to treat endometriosis-related symptoms either after surgery or as an alternative to the surgical excision of endometriosis. The effectiveness of therapies, the dose of drugs, the length of treatment and the adverse effects are examined. TAKE HOME MESSAGE: Medical therapies can efficaciously reduce the severity of pain symptoms caused by endometriosis. Recurrence of symptoms is common after discontinuation of medical therapies; therefore, the choice of the therapy should be based not only on the improvements of symptoms but also on the potential adverse effects and patients' satisfaction.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Gonadotrophin-releasing hormone analogues for pain associated with endometriosis
Prentice, A., Deary, A., Goldbeck-Wood, S., Farquhar, C., & Smith, S. (1999) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000346 · Cited by 116
RetractedGiudice, L. C., & Kao, L. C. (2004) · The Lancet · doi:10.1016/s0140-6736(04)17403-5 · Cited by 3,166
Bulun, S. E. (2009) · New England Journal of Medicine · doi:10.1056/nejmra0804690 · Cited by 1,772
Abbott, J. A. (2003) · Human Reproduction · doi:10.1093/humrep/deg275 · Cited by 403
Petta, C. A., Ferriani, R. A., Abrao, M. S., Hassan, D., Rosa e Silva, J. C., Podgaec, S., & Bahamondes, L. (2005) · Human Reproduction · doi:10.1093/humrep/deh869 · Cited by 363 · cited 6×
“A prospective non-comparative observational study including 34 women with endometriosis demonstrated that the use of the Lng-IUD for 6 months significantly reduces not only pain and menstrual symptoms but also the extent of the disease observed at second-look laparoscopy [41].”
BackgroundInfluentialLong-term pituitary down-regulation before in vitro fertilization (IVF) for women with endometriosis
Sallam, H. N., Garcia-Velasco, J. A., Dias, S., Arici, A., Abou-Setta, A. M., & Jaafar, S. H. (2006) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004635.pub2 · Cited by 349 · cited 1×
“A Cochrane review including three RCTs (165 women) demonstrated that the administration of GnRH analogues for at least 3 months (up to 6 months) before assisted reproductive technologies increase the odds of clinical pregnancy by at least four-fold [71].”
MethodThe effect of surgery for symptomatic endometriosis: the other side of the story
Vercellini, P., Crosignani, P. G., Abbiati, A., Somigliana, E., Viganò, P., & Fedele, L. (2009) · Human Reproduction Update · doi:10.1093/humupd/dmn062 · Cited by 339
Vercellini, P., Trespidi, L., Colombo, A., Vendola, N., Marchini, M., & Crosignani, P. G. (1993) · Fertility and Sterility · doi:10.1016/s0015-0282(16)56039-7 · Cited by 311 · cited 1×
“An openlabel RCT demonstrated that a low-dose monophasic oral contraceptive administered in a cyclic regimen for 6 months to women with endometriosis is as effective as GnRH analogues in treating dyspareunia and non-menstrual pelvic pain [44].”
BackgroundUse of a levonorgestrel-releasing intrauterine device in the treatment of rectovaginal endometriosis
Fedele, L., Bianchi, S., Zanconato, G., Portuese, A., & Raffaelli, R. (2001) · Fertility and Sterility · doi:10.1016/s0015-0282(00)01759-3 · Cited by 290 · cited 1×
“In addition, it determines a significant decrease in the size of rectovaginal endometriotic nodules evaluated by transrectal and transvaginal ultrasonography [40].”
BackgroundVercellini, P., Frontino, G., De Giorgi, O., Pietropaolo, G., Pasin, R., & Crosignani, P. G. (2003) · Fertility and Sterility · doi:10.1016/s0015-0282(03)00794-5 · Cited by 289 · cited 1×
“A prospective study involving 55 patients demonstrated that continuous administration of low-dose oral contraceptive is more effective than the cyclic regimen in controlling pain symptoms after surgical excision of endometriosis [46].”
BackgroundHarada, T., Momoeda, M., Taketani, Y., Hoshiai, H., & Terakawa, N. (2008) · Fertility and Sterility · doi:10.1016/j.fertnstert.2007.08.051 · Cited by 289 · cited 1×
“A recent, double-blind RCT demonstrated that the administration of a low-dose oral contraceptive pill significantly reduces the severity of dysmenorrhoea in women with endometriosis [45].”
BackgroundTreatment of severe postmenopausal endometriosis with an aromatase inhibitor
Takayama, K., Zeitoun, K., Gunby, R. T., Sasano, H., Carr, B. R., & Bulun, S. E. (1998) · Fertility and Sterility · doi:10.1016/s0015-0282(98)00022-3 · Cited by 270
Vercellini, P., Frontino, G., De Giorgi, O., Aimi, G., Zaina, B., & Crosignani, P. G. (2003) · Fertility and Sterility · doi:10.1016/s0015-0282(03)00608-3 · Cited by 263
Aromatase: a key molecule in the pathophysiology of endometriosis and a therapeutic target
Zeitoun, K. M., & Bulun, S. E. (1999) · Fertility and Sterility · doi:10.1016/s0015-0282(99)00393-3 · Cited by 256 · cited 1×
“Recent studies suggested that endometriotic implants synthesize oestrogens locally because of inappropriate expression of the enzyme aromatase [77].”
BackgroundTelimaa, S., Puolakka, J., & Kauppila, A. (1987) · Gynecological Endocrinology · doi:10.3109/09513598709082692 · Cited by 241 · cited 1×
“demonstrated that the administration of MPA (100 mg/day) for 6 months is as effective as danazol in the treatment of pain both after diagnostic laparoscopy [17] and after surgical excision of endometriosis [18].”
BackgroundSoysal, S. (2004) · Human Reproduction · doi:10.1093/humrep/deh035 · Cited by 227 · cited 2×
“[84] 40 Anastrozole (oral, 1 mg/day) Goreselin (3.”
BackgroundDanazol for pelvic pain associated with endometriosis
Farquhar, C., Prentice, A., Singla, A. A., & Selak, V. (2007) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000068.pub2 · Cited by 210 · cited 1×
“However, the long-term use of danazol is limited by the occurrence of androgenic adverse effects [52].”
BackgroundVercellini, P., Pietropaolo, G., De Giorgi, O., Pasin, R., Chiodini, A., & Crosignani, P. G. (2005) · Fertility and Sterility · doi:10.1016/j.fertnstert.2005.03.083 · Cited by 197 · cited 1×
“5 mg/day) is at least as effective as an oestrogen--progestogen combination containing cyproterone acetate in treating dysmenorrhoea, deep dyspareunia, chronic pelvic pain and dyschezia [26].”
BackgroundPostoperative oral contraceptive exposure and risk of endometrioma recurrence
Vercellini, P., Somigliana, E., Daguati, R., Vigano, P., Meroni, F., & Crosignani, P. G. (2008) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2007.11.010 · Cited by 196
Vercellini, P., De Giorgi, O., Mosconi, P., Stellato, G., Vicentini, S., & Crosignani, P. G. (2002) · Fertility and Sterility · doi:10.1016/s0015-0282(01)02951-x · Cited by 180 · cited 2×
“An RCT compared the efficacy and safety of a 6-month administration of cyproterone acetate versus an oral contraceptive in the treatment of endometriosis-associated recurrent pelvic pain [29].”
BackgroundMethodCrosignani, P. G., Luciano, A., Ray, A., & Bergqvist, A. (2006) · Human Reproduction · doi:10.1093/humrep/dei290 · Cited by 179
Schlaff, W. D., Carson, S. A., Luciano, A., Ross, D., & Bergqvist, A. (2006) · Fertility and Sterility · doi:10.1016/j.fertnstert.2005.07.1315 · Cited by 168
Lockhat, F. B., Emembolu, J. O., & Konje, J. C. (2005) · Human Reproduction · doi:10.1093/humrep/deh650 · Cited by 166
Vercellini, P., De Giorgi, O., Oldani, S., Cortesi, I., Panazza, S., & Crosignani, P. G. (1996) · American Journal of Obstetrics and Gynecology · doi:10.1016/s0002-9378(96)70152-7 · Cited by 161 · cited 1×
“An RCT compared the treatment for 1 year with intramuscular depot MPA (DMPA, 150 mg every 3 months) with a cyclic monophasic oral contraceptive combined with oral danazol (50 mg/day for 21 days of each 28-day cycle) [19].”
MethodSeracchioli, R., Mabrouk, M., Frascà, C., Manuzzi, L., Savelli, L., & Venturoli, S. (2010) · Fertility and Sterility · doi:10.1016/j.fertnstert.2009.03.083 · Cited by 158
Cosson, M., Querleu, D., Donnez, J., Madelenat, P., Konincks, P., Audebert, A., & Manhes, H. (2002) · Fertility and Sterility · doi:10.1016/s0015-0282(01)03270-8 · Cited by 153
Lockhat, F. B. (2004) · Human Reproduction · doi:10.1093/humrep/deh004 · Cited by 135 · cited 1×
“A prospective non-comparative observational study including 34 women with endometriosis demonstrated that the use of the Lng-IUD for 6 months significantly reduces not only pain and menstrual symptoms but also the extent of the disease observed at second-look laparoscopy [41].”
BackgroundWalch, K., Unfried, G., Huber, J., Kurz, C., van Trotsenburg, M., Pernicka, E., & Wenzl, R. (2009) · Contraception · doi:10.1016/j.contraception.2008.07.017 · Cited by 128
Endometriosis in pregnant and non-pregnant women at tubal sterilization
Moen, M. H., & Muus, K. M. (1991) · Human Reproduction · doi:10.1093/oxfordjournals.humrep.a137411 · Cited by 118
Epidemiology of endometriosis in infertile women
Matorras, R., Rodíquez, F., Pijoan, J. I., Ramón, O., de Terán, G. G., & Rodríguez-Escudero, F. (1995) · Fertility and Sterility · doi:10.1016/s0015-0282(16)57293-8 · Cited by 109 · cited 1×
“It is found in up to 20% of asymptomatic women [1], in up to 30% of women with infertility [2] and in up to 50% of those with pain symptoms [3,4].”
BackgroundNorethisterone acetate in the treatment of colorectal endometriosis: a pilot study
Ferrero, S., Camerini, G., Ragni, N., Venturini, P. L., Biscaldi, E., & Remorgida, V. (2010) · Human Reproduction · doi:10.1093/humrep/dep361 · Cited by 107
Self-citationEffects of Triptorelin Versus Placebo on the Symptoms of Endometriosis
Bergqvist, A., Bergh, T., Hogström, L., Mattsson, S., Nordenskjöld, F., & Rasmussen, C. (1998) · Fertility and Sterility · doi:10.1016/s0015-0282(98)00019-3 · Cited by 99
Razzi, S., Luisi, S., Ferretti, C., Calonaci, F., Gabbanini, M., Mazzini, M., & Petraglia, F. (2007) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/j.ejogrb.2006.08.002 · Cited by 62 · cited 1×
“More recently, an RCT including 40 women compared the efficacy of a 6-month treatment with desogestrel (75 μg/day) and the oral contraceptive pill in improving dysmenorrhea and/or pelvic pain that recurred after conservative surgery for endometriosis [38].”
Background
Cited by
“Waiting for Godot”: a commonsense approach to the medical treatment of endometriosis
Vercellini, P., Crosignani, P., Somigliana, E., Vigano, P., Frattaruolo, M. P., & Fedele, L. (2011) · Human Reproduction · doi:10.1093/humrep/deq302 · Cited by 180
“…2006; Chlouber et al., 2006; Crosignani et al., 2006a; Mihalyi et al., 2006; Hompes and Mijatovic, 2007; Fedele et al., 2008; Guo, 2008; Panay, 2008; Ferrero et al., 2010a) and concluded that we were entering a new therapeutic era when several compounds would become available which could act on…”
BackgroundCurrent and emerging treatment options for endometriosis
Ferrero, S., Evangelisti, G., & Barra, F. (2018) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2018.1494154 · Cited by 152
“Progestins can be classified according their chemical structure in 17-hydroxyprogesterone derivatives and in 19-nortestosterone derivatives [6,27].”
BackgroundSelf-citationUse of aromatase inhibitors to treat endometriosis-related pain symptoms: a systematic review
Ferrero, S., Gillott, D. J., Venturini, P. L., & Remorgida, V. (2011) · Reproductive Biology and Endocrinology · doi:10.1186/1477-7827-9-89 · Cited by 109
“However, women with endometriosis should receive a chronic treatment [5,48] and the optimal therapy should balance potential benefits and side affects.”
BackgroundSelf-citationBarra, F., Scala, C., & Ferrero, S. (2018) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1080/17425255.2018.1461840 · Cited by 100
Self-citationLeone Roberti Maggiore, U., Remorgida, V., Scala, C., Tafi, E., Venturini, P. L., & Ferrero, S. (2014) · Acta Obstetricia et Gynecologica Scandinavica · doi:10.1111/aogs.12326 · Cited by 80
Self-citation
Metadata
- Authors
- Ferrero, S., Remorgida, V., & Venturini, P. L.
- Venue
- Expert Opinion on Pharmacotherapy
- Publisher
- Informa Healthcare
- Published
- 2010-03-15
- Volume
- 11
- Issue
- 7
- Pages
- 1123-1134
- ISSN
- 1465-6566 (ISSN-L)
- 1744-7666
- OpenAlex
- W2137876945
- Cited by
- 58
- References
- 33
- FWCI
- 5.86
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.